These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23912386)

  • 1. Vitamin D in the cancer patient.
    Kennel KA; Drake MT
    Curr Opin Support Palliat Care; 2013 Sep; 7(3):272-7. PubMed ID: 23912386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
    Osborne JE; Hutchinson PE
    Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of vitamin D in the prevention and the additional therapy of cancers].
    Speer G
    Magy Onkol; 2010 Dec; 54(4):303-14. PubMed ID: 21163761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of the potential of vitamin D to prevent cancer.
    Ingraham BA; Bragdon B; Nohe A
    Curr Med Res Opin; 2008 Jan; 24(1):139-49. PubMed ID: 18034918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health outcomes of vitamin D. Part II. Role in prevention of diseases.
    Wranicz J; Szostak-Węgierek D
    Rocz Panstw Zakl Hig; 2014; 65(4):273-9. PubMed ID: 25526571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vitamin D and cancer].
    Yamana K; Saito H; Takenouchi K; Azuma Y; Ishizuka S
    Clin Calcium; 2006 Jul; 16(7):1147-53. PubMed ID: 16816475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy.
    Trump DL; Deeb KK; Johnson CS
    Cancer J; 2010; 16(1):1-9. PubMed ID: 20164683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor polymorphisms and cancer.
    Gandini S; Gnagnarella P; Serrano D; Pasquali E; Raimondi S
    Adv Exp Med Biol; 2014; 810():69-105. PubMed ID: 25207361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D and cancer: an overview on epidemiological studies.
    Ordóñez Mena JM; Brenner H
    Adv Exp Med Biol; 2014; 810():17-32. PubMed ID: 25207358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
    PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D in cancer chemoprevention.
    Giammanco M; Di Majo D; La Guardia M; Aiello S; Crescimannno M; Flandina C; Tumminello FM; Leto G
    Pharm Biol; 2015; 53(10):1399-434. PubMed ID: 25856702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D status and cancer incidence and mortality.
    Shui I; Giovannucci E
    Adv Exp Med Biol; 2014; 810():33-51. PubMed ID: 25207359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States).
    Giovannucci E
    Cancer Causes Control; 2005 Mar; 16(2):83-95. PubMed ID: 15868450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer survivors and vitamin D: a review.
    Hines SL; Jorn HK; Thompson KM; Larson JM
    Nutrition; 2010 Mar; 26(3):255-62. PubMed ID: 20004077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Umbrella Review on the Relationship between Vitamin D Levels and Cancer.
    Schömann-Finck M; Reichrath J
    Nutrients; 2024 Aug; 16(16):. PubMed ID: 39203855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer.
    Leyssens C; Verlinden L; Verstuyf A
    Endocr Relat Cancer; 2013 Apr; 20(2):R31-47. PubMed ID: 23319494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue.
    Giangreco AA; Vaishnav A; Wagner D; Finelli A; Fleshner N; Van der Kwast T; Vieth R; Nonn L
    Cancer Prev Res (Phila); 2013 May; 6(5):483-94. PubMed ID: 23503652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D and breast cancer: emerging concepts.
    Mehta RG; Peng X; Alimirah F; Murillo G; Mehta R
    Cancer Lett; 2013 Jun; 334(1):95-100. PubMed ID: 23142286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology.
    Vashi PG; Trukova K; Lammersfeld CA; Braun DP; Gupta D
    Nutr J; 2010 Nov; 9():60. PubMed ID: 21092237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.